CNBM
03323
CONCH CEMENT
00914
FE HORIZON
03360
CKI HOLDINGS
01038
CGS
06881
(Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 81.67%-125.81B | ---- | -2,285.41%-686.22B | ---- | -6.39%31.4B | ---- | -49.60%33.54B | ---- | 79.62%66.55B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 47.92%-1.28B | ---- | 56.84%-2.46B | ---- | -24.43%-5.69B | ---- | -17.74%-4.57B | ---- | 4.76%-3.88B |
Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | 42.11%-11M | ---- | 94.06%-19M | ---- | 12.09%-320M |
Investment loss (gain) | ---- | -100.20%-39M | ---- | 1,330.17%19.72B | ---- | 146.48%1.38B | ---- | -439.47%-2.97B | ---- | 162.34%874M |
Impairment and provisions: | ---- | 15.59%28.45B | ---- | 2,109.16%24.61B | ---- | 536.57%1.11B | ---- | --175M | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | 7.99%7.61B | ---- | --7.05B | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of goodwill | ---- | -70.15%2.81B | ---- | 746.23%9.43B | ---- | 536.57%1.11B | ---- | --175M | ---- | ---- |
-Other impairments and provisions | ---- | 121.55%18.02B | ---- | --8.13B | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | -99.35%234M | ---- | 1,142.51%35.76B | ---- | -441.01%-3.43B | ---- | 71.06%-634M | ---- | 69.80%-2.19B |
-Fair value of investment properties (increase) | ---- | -105.78%-1.81B | ---- | 2,546.56%31.27B | ---- | 15.70%-1.28B | ---- | -12.88%-1.52B | ---- | 84.22%-1.34B |
-Derivative financial instruments fair value (increase) | ---- | ---- | ---- | 217.04%2.56B | ---- | -122.53%-2.18B | ---- | -23.09%-981M | ---- | -197.20%-797M |
-Other fair value changes | ---- | 5.42%2.04B | ---- | 6,145.16%1.94B | ---- | -98.34%31M | ---- | 3,752.94%1.86B | ---- | -111.67%-51M |
Asset sale loss (gain): | ---- | -104.11%-323M | ---- | 1,155.44%7.86B | ---- | 37.08%-745M | ---- | 45.34%-1.18B | ---- | -131.39%-2.17B |
-Loss (gain) from sale of subsidiary company | ---- | -71.91%564M | ---- | 1,504.20%2.01B | ---- | 87.12%-143M | ---- | 49.50%-1.11B | ---- | -219,700.00%-2.2B |
-Loss (gain) on sale of property, machinery and equipment | ---- | -101.26%-28M | ---- | 74,333.33%2.23B | ---- | 75.00%-3M | ---- | ---12M | ---- | ---- |
-Loss (gain) from selling other assets | ---- | -123.68%-859M | ---- | 705.68%3.63B | ---- | -866.13%-599M | ---- | -293.75%-62M | ---- | 111.07%32M |
Depreciation and amortization: | ---- | -37.22%7.64B | ---- | 127.68%12.17B | ---- | 22.36%5.35B | ---- | 67.24%4.37B | ---- | 31.04%2.61B |
-Depreciation | ---- | -38.75%5.09B | ---- | 195.23%8.3B | ---- | -2.33%2.81B | ---- | 35.80%2.88B | ---- | 19.64%2.12B |
-Other depreciation and amortization | ---- | -33.94%2.56B | ---- | 52.74%3.87B | ---- | 70.02%2.54B | ---- | 202.43%1.49B | ---- | 122.07%493M |
Financial expense | ---- | 14.08%47.48B | ---- | 231.90%41.62B | ---- | -33.08%12.54B | ---- | 123.67%18.74B | ---- | -6.14%8.38B |
Exchange Loss (gain) | ---- | 903.02%9.59B | ---- | 86.14%-1.19B | ---- | -353.37%-8.62B | ---- | -39.90%3.4B | ---- | 374.84%5.66B |
Special items | ---- | 222.90%13.93B | ---- | -127.55%-11.33B | ---- | -0.41%41.13B | ---- | -33.85%41.3B | ---- | 51.77%62.43B |
Operating profit before the change of operating capital | ---- | 96.40%-20.14B | ---- | -851.82%-559.45B | ---- | -19.25%74.41B | ---- | -33.20%92.15B | ---- | 70.62%137.94B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -312.26%-329M | ---- | -28.24%155M | ---- | 198.63%216M | ---- | -273.81%-219M | ---- | 21.15%126M |
Developing property (increase)decrease | ---- | -44.49%205.95B | ---- | 1,720.87%371.03B | ---- | 79.50%-22.89B | ---- | -24.01%-111.64B | ---- | 55.73%-90.03B |
Accounts receivable (increase)decrease | ---- | -133.02%-9.84B | ---- | 239.79%29.8B | ---- | -420.06%-21.32B | ---- | -38.87%6.66B | ---- | 111.78%10.9B |
Accounts payable increase (decrease) | ---- | -174.98%-146.19B | ---- | 26.02%194.96B | ---- | 418.43%154.7B | ---- | -51.95%29.84B | ---- | -58.56%62.1B |
Special items for working capital changes | ---- | 9,816.80%12.15B | ---- | -100.44%-125M | ---- | 1,549.82%28.11B | ---- | -88.10%1.7B | ---- | 196.41%14.31B |
Cash from business operations | ---- | 14.38%41.61B | ---- | -82.94%36.37B | ---- | 1,053.04%213.23B | 1,455.27%59.44B | -86.34%18.49B | -107.03%-4.39B | 269.39%135.35B |
Other taxs | ---- | -24.47%-17.03B | ---- | 45.57%-13.68B | ---- | -31.87%-25.13B | -65.21%-16.94B | 25.29%-19.06B | 37.55%-10.26B | -50.07%-25.51B |
Interest paid - operating | ---- | 50.48%-36.79B | ---- | 4.79%-74.29B | ---- | -16.83%-78.03B | -25.52%-38.89B | -21.24%-66.79B | -12.10%-30.98B | -1.88%-55.09B |
Special items of business | 26.59%5.44B | ---- | 108.88%4.3B | ---- | ---48.36B | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | 26.59%5.44B | 76.32%-12.22B | 108.88%4.3B | -146.88%-51.6B | -1,438.36%-48.36B | 263.40%110.06B | 107.92%3.61B | -223.03%-67.36B | -349.12%-45.62B | 136.26%54.75B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -35.02%1.19B | ---- | -61.91%1.84B | ---- | 25.39%4.82B | -0.80%2.1B | -1.03%3.84B | -22.69%2.11B | -4.76%3.88B |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | -64.84%64M | -48.04%53M | -70.16%182M | --102M | -0.65%610M |
Loan receivable (increase) decrease | ---- | 66.72%-7.91B | ---- | -392.60%-23.78B | ---- | 70.46%-4.83B | -320.62%-4.51B | -29.02%-16.34B | 88.23%-1.07B | -37.97%-12.67B |
Sale of fixed assets | ---- | 18.49%6.93B | ---- | 23,304.00%5.85B | ---- | -94.09%25M | -27.38%1.65B | 34.71%423M | 64.14%2.28B | -13.26%314M |
Purchase of fixed assets | ---- | 69.52%-7.98B | ---- | -111.47%-26.17B | ---- | -4.54%-12.38B | -36.39%-6.03B | -23.39%-11.84B | 47.15%-4.42B | 33.23%-9.59B |
Purchase of intangible assets | ---- | -7.92%-3.64B | ---- | 43.12%-3.37B | ---- | -78.35%-5.93B | ---- | -339.81%-3.33B | ---- | -77.46%-756M |
Sale of subsidiaries | ---- | -77.19%12.52B | ---- | 22,389.75%54.88B | ---- | -91.26%244M | 4.21%99M | 67.05%2.79B | -94.03%95M | 55,633.33%1.67B |
Acquisition of subsidiaries | ---- | ---- | ---- | 5.16%-3.84B | ---- | 68.13%-4.05B | 73.23%-2.69B | -28.95%-12.71B | -47.43%-10.06B | 73.36%-9.86B |
Recovery of cash from investments | ---- | -89.13%3B | ---- | 183.84%27.56B | ---- | -9.68%9.71B | -26.38%3.14B | -79.95%10.75B | -84.93%4.27B | -44.59%53.63B |
Cash on investment | ---- | 63.90%-17.31B | ---- | -268.83%-47.94B | ---- | 50.44%-13B | -19.52%-4.52B | 62.74%-26.23B | 86.37%-3.79B | 19.72%-70.39B |
Other items in the investment business | -134.78%-6.82B | -82.50%102M | 199.88%19.59B | -51.17%583M | -899.90%-19.62B | 141.84%1.19B | -63.50%-1.96B | 83.41%-2.85B | 88.59%-1.2B | -2,501.97%-17.2B |
Net cash from investment operations | -134.78%-6.82B | 9.07%-13.1B | 199.88%19.59B | 40.29%-14.41B | -54.74%-19.62B | 56.38%-24.13B | -8.47%-12.68B | 8.37%-55.31B | 59.07%-11.69B | -27.13%-60.36B |
Net cash before financing | -105.77%-1.38B | 61.64%-25.32B | 135.14%23.89B | -176.81%-66.01B | -649.84%-67.97B | 170.06%85.94B | 84.18%-9.07B | -2,084.98%-122.67B | -459.45%-57.31B | 97.17%-5.61B |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -54.32%51.84B | ---- | -72.47%113.49B | ---- | -18.75%412.19B | -1.33%242.68B | 39.89%507.33B | 34.02%245.96B | -25.27%362.66B |
Refund | ---- | 90.81%-24.05B | ---- | 44.71%-261.6B | ---- | -12.08%-473.17B | -46.64%-246.16B | 5.79%-422.16B | 30.15%-167.87B | -32.22%-448.09B |
Issuing shares | ---- | ---- | ---- | -99.26%28M | ---- | 1,187.12%3.8B | 76.92%46M | -97.99%295M | -99.82%26M | 2,835.40%14.68B |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | -18.60%54.52B | 278.89%72.64B | --66.99B | -55.43%19.17B |
Dividends paid - financing | ---- | ---- | ---- | 99.19%-467M | ---- | -2,002.58%-57.78B | -7,829.71%-34.97B | 90.07%-2.75B | ---441M | -11,387.14%-27.68B |
Absorb investment income | ---- | ---- | ---- | 88.40%74.93B | ---- | -15.26%39.77B | -36.97%14.26B | 11.55%46.93B | -22.20%22.62B | -64.70%42.07B |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 89.45%-441M | ---- | 77.45%-4.18B | ---22.52B | -40.04%-18.54B | ---- | 89.30%-13.24B |
Other items of the financing business | 104.19%1.05B | 80.70%-2.05B | 33.06%-25.07B | -442.88%-10.64B | -360.42%-37.45B | 107.82%3.1B | 74.87%-8.13B | -221.07%-39.69B | -216.34%-32.36B | 201.74%32.78B |
Net cash from financing operations | 104.19%1.05B | 127.74%24.22B | 33.06%-25.07B | -13.55%-87.3B | -5,815.64%-37.45B | -153.70%-76.89B | -100.47%-633M | 911.08%143.16B | 829.66%134.72B | -111.54%-17.65B |
Effect of rate | 940.00%42M | 125.00%2M | 94.12%-5M | 97.74%-8M | -121.85%-85M | -282.47%-354M | 527.42%389M | -68.76%194M | -79.26%62M | 171.38%621M |
Net Cash | 72.02%-329M | 99.28%-1.1B | 98.88%-1.18B | -1,794.02%-153.31B | -987.02%-105.42B | -55.85%9.05B | -112.53%-9.7B | 188.11%20.5B | 1,722.63%77.41B | 48.92%-23.27B |
Begining period cash | -20.26%4.33B | -96.58%5.44B | -96.58%5.44B | 5.80%158.75B | 5.80%158.75B | 16.00%150.06B | 16.00%150.06B | -14.90%129.36B | -14.90%129.36B | -23.39%152.01B |
Cash at the end | -4.87%4.05B | -20.26%4.33B | -92.01%4.25B | -96.58%5.44B | -62.17%53.25B | 5.80%158.75B | -31.95%140.75B | 16.00%150.06B | 32.12%206.83B | -14.90%129.36B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | -- | -- | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.